86 related articles for article (PubMed ID: 12855009)
1. Leucine at codon 428 in the ninth heptad of thyroid hormone receptor beta1 is necessary for interactions with the transcriptional cofactors and functions regardless of dimer formations.
Monden T; Yamada M; Ishii S; Hosoya T; Satoh T; Wondisford FE; Hollenberg AN; Mori M
Thyroid; 2003 May; 13(5):427-35. PubMed ID: 12855009
[TBL] [Abstract][Full Text] [Related]
2. Protein-protein interaction domains and the heterodimerization of thyroid hormone receptor variant alpha2 with retinoid X receptors.
Wu Y; Yang YZ; Koenig RJ
Mol Endocrinol; 1998 Oct; 12(10):1542-50. PubMed ID: 9773977
[TBL] [Abstract][Full Text] [Related]
3. Conserved amino acids in the ligand-binding and tau(i) domains of the peroxisome proliferator-activated receptor alpha are necessary for heterodimerization with RXR.
Gorla-Bajszczak A; Juge-Aubry C; Pernin A; Burger AG; Meier CA
Mol Cell Endocrinol; 1999 Jan; 147(1-2):37-47. PubMed ID: 10195690
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
5. The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation.
Au-Fliegner M; Helmer E; Casanova J; Raaka BM; Samuels HH
Mol Cell Biol; 1993 Sep; 13(9):5725-37. PubMed ID: 8395010
[TBL] [Abstract][Full Text] [Related]
6. Amino acid substitutions of thyroid hormone receptor-beta at codon 435 with resistance to thyroid hormone selectively alter homodimer formation.
Nomura Y; Nagaya T; Tsukaguchi H; Takamatsu J; Seo H
Endocrinology; 1996 Oct; 137(10):4082-6. PubMed ID: 8828460
[TBL] [Abstract][Full Text] [Related]
7. Two separate NCoR (nuclear receptor corepressor) interaction domains mediate corepressor action on thyroid hormone response elements.
Cohen RN; Wondisford FE; Hollenberg AN
Mol Endocrinol; 1998 Oct; 12(10):1567-81. PubMed ID: 9773980
[TBL] [Abstract][Full Text] [Related]
8. A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone.
Wu SY; Cohen RN; Simsek E; Senses DA; Yar NE; Grasberger H; Noel J; Refetoff S; Weiss RE
J Clin Endocrinol Metab; 2006 May; 91(5):1887-95. PubMed ID: 16464943
[TBL] [Abstract][Full Text] [Related]
9. Thyroid hormone receptor variant alpha2. Role of the ninth heptad in dna binding, heterodimerization with retinoid X receptors, and dominant negative activity.
Yang YZ; Burgos-Trinidad M; Wu Y; Koenig RJ
J Biol Chem; 1996 Nov; 271(45):28235-42. PubMed ID: 8910441
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor mediates cross-talk with thyroid hormone receptor by competition for retinoid X receptor. Possible role of a leucine zipper-like heptad repeat.
Juge-Aubry CE; Gorla-Bajszczak A; Pernin A; Lemberger T; Wahli W; Burger AG; Meier CA
J Biol Chem; 1995 Jul; 270(30):18117-22. PubMed ID: 7629123
[TBL] [Abstract][Full Text] [Related]
11. DNA-independent and DNA-dependent mechanisms regulate the differential heterodimerization of the isoforms of the thyroid hormone receptor with retinoid X receptor.
Reginato MJ; Zhang J; Lazar MA
J Biol Chem; 1996 Nov; 271(45):28199-205. PubMed ID: 8910436
[TBL] [Abstract][Full Text] [Related]
12. The oligomeric state of thyroid receptor regulates hormone binding kinetics.
Cunha Lima ST; Rodrigues ED
J Endocrinol; 2011 Jul; 210(1):125-34. PubMed ID: 21508093
[TBL] [Abstract][Full Text] [Related]
13. A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.
Tagami T; Gu WX; Peairs PT; West BL; Jameson JL
Mol Endocrinol; 1998 Dec; 12(12):1888-902. PubMed ID: 9849963
[TBL] [Abstract][Full Text] [Related]
14. Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding.
Pissios P; Tzameli I; Kushner P; Moore DD
Mol Cell; 2000 Aug; 6(2):245-53. PubMed ID: 10983973
[TBL] [Abstract][Full Text] [Related]
15. Identification of critical residues for heterodimerization within the ligand-binding domain of retinoid X receptor.
Lee SK; Na SY; Kim HJ; Soh J; Choi HS; Lee JW
Mol Endocrinol; 1998 Mar; 12(3):325-32. PubMed ID: 9514150
[TBL] [Abstract][Full Text] [Related]
16. The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains.
Cohen RN; Brzostek S; Kim B; Chorev M; Wondisford FE; Hollenberg AN
Mol Endocrinol; 2001 Jul; 15(7):1049-61. PubMed ID: 11435607
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of DNA binding affinity and dimerization properties of wild-type and mutant thyroid hormone receptor beta1.
Takeda T; Nagasawa T; Miyamoto T; Minemura K; Hashizume K; Degroot LJ
Thyroid; 2000 Jan; 10(1):11-8. PubMed ID: 10691308
[TBL] [Abstract][Full Text] [Related]
18. Human thyroid receptor forms tetramers in solution, which dissociate into dimers upon ligand binding.
Figueira AC; Dias SM; Santos MA; Apriletti JW; Baxter JD; Webb P; Neves FA; Simeoni LA; Ribeiro RC; Polikarpov I
Cell Biochem Biophys; 2006; 44(3):453-62. PubMed ID: 16679533
[TBL] [Abstract][Full Text] [Related]
19. Requirement of corepressor binding of thyroid hormone receptor mutants for dominant negative inhibition.
Nagaya T; Fujieda M; Seo H
Biochem Biophys Res Commun; 1998 Jun; 247(3):620-3. PubMed ID: 9647743
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
